These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 30274771)

  • 1. Blood pressure control and impact on cardiovascular events in patients with type 2 diabetes mellitus: A critical analysis of the literature.
    Vargas-Uricoechea H; Cáceres-Acosta MF
    Clin Investig Arterioscler; 2019; 31(1):31-47. PubMed ID: 30274771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ESH-ESC guidelines for the management of hypertension.
    Erdine S; Ari O; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn KH; Rodicio JL; Ruilope LM; Staessen J; van Zwieten P; Waeber B; Williams B
    Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [New treatment strategies for hypertension. Which guidelines and how to apply them].
    Blacher J; Baes M; Marchal A; Younes W; Legedz L; Safar M
    Presse Med; 2005 Oct; 34(18):1279-85. PubMed ID: 16269990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of hypertension in patients with diabetes: the place of angiotensin-II receptor blockers.
    Kalaitzidis R; Bakris G
    Diabetes Obes Metab; 2009 Aug; 11(8):757-69. PubMed ID: 19519867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arterial hypertension defeated? Attacked from another angle.
    Pongrac Barlovic D; Cooper ME
    Diab Vasc Dis Res; 2009 Oct; 6(4):221-2. PubMed ID: 20368214
    [No Abstract]   [Full Text] [Related]  

  • 6. Management of hypertension in diabetic patients: outstanding issues.
    Camafort-Babkowski M; Barrios V; Coca A
    Expert Rev Cardiovasc Ther; 2011 Jun; 9(6):721-8. PubMed ID: 21714603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are there new threshold and goals in the treatment of arterial hypertension?
    Segura J; Ruilope LM
    Eur J Clin Invest; 2012 Aug; 42(8):914-20. PubMed ID: 22404687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of blood-pressure-lowering treatment on outcome incidence in hypertension: 10 - Should blood pressure management differ in hypertensive patients with and without diabetes mellitus? Overview and meta-analyses of randomized trials.
    Thomopoulos C; Parati G; Zanchetti A
    J Hypertens; 2017 May; 35(5):922-944. PubMed ID: 28141660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Choice of antihypertensive drug in the diabetic patient.
    Ong HT; Cheah JS
    MedGenMed; 2005 May; 7(2):74. PubMed ID: 16369452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How early should blood pressure control be achieved for optimal cardiovascular outcomes?
    Weir MR; Zappe D; Orloski LA; Sowers JR
    J Hum Hypertens; 2011 Apr; 25(4):211-7. PubMed ID: 20596060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cardiovascular risk stratification and therapeutic implications in arterial hypertension].
    Handschin A; Henny-Fullin K; Buess D; Dieterle T
    Ther Umsch; 2015 Jun; 72(6):361-8. PubMed ID: 26098185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treating high blood pressure in diabetes: the evidence.
    Adler AI
    Semin Vasc Med; 2002 May; 2(2):127-37. PubMed ID: 16222604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Blood pressure targets in patients with diabetes mellitus : What are optimum values?].
    Dederer J; Bewarder Y; Mahfoud F; Böhm M
    Herz; 2019 May; 44(3):231-237. PubMed ID: 30847509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of hypertension in children and adolescents with the metabolic syndrome.
    Puri M; Flynn JT
    J Cardiometab Syndr; 2006; 1(4):259-68. PubMed ID: 17679805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Success of blood pressure reduction in diabetic patients].
    Schernthaner G
    Dtsch Med Wochenschr; 2006 Dec; 131 Suppl 8():S247-51. PubMed ID: 17139580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is treatment of hypertension with acetylcholine esterase inhibitors (ACEIs) superior to other antihypertensives in preventing significant cardiovascular events and death in patients with type 2 diabetes?
    McConaghy JR
    J Fam Pract; 2000 Nov; 49(11):980. PubMed ID: 11093559
    [No Abstract]   [Full Text] [Related]  

  • 17. [Should blood pressure goals be changed in hypertension treatment?].
    Camafort-Babkowski M
    Hipertens Riesgo Vasc; 2017 Jan; 34 Suppl 1():15-18. PubMed ID: 29703397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ideal blood pressure target to prevent cardiovascular disease in type 2 diabetes: a neutral viewpoint.
    Frontoni S; Solini A; Fioretto P; Natali A; Zuccalà A; Cosentino F; Penno G;
    Nutr Metab Cardiovasc Dis; 2014 Jun; 24(6):577-84. PubMed ID: 24582686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inertia or inaction? Blood pressure management and cardiovascular risk in diabetes.
    Owen AJ; Retegan C; Rockell M; Jennings G; Reid CM
    Clin Exp Pharmacol Physiol; 2009 Jul; 36(7):643-7. PubMed ID: 19076166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of angiotensin II type 1 receptor antagonists in elderly patients with hypertension.
    Thomas GN; Chan P; Tomlinson B
    Drugs Aging; 2006; 23(2):131-55. PubMed ID: 16536636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.